Evidence map›Paper›PMID 32541654›Full record

ArticleNature communications2020

An Erg-driven transcriptional program controls B cell lymphopoiesis.

Ashley P Ng, Hannah D Coughlan, Soroor Hediyeh-Zadeh, Kira Behrens, Timothy M Johanson, Michael Sze Yuan Low, Charles C Bell, Omer Gilan, Yih-Chih Chan, Andrew J Kueh and 18 more

Abstract read
In one paragraph

Article in Nature communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. E-selectin in vascular pathophysiology.Frontiers in immunology · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors.

Ashley P NgBlood Cells and Blood Cancer Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3052, Australia. ang@wehi.edu.au.ORCID http://orcid.org/0000-0001-9690-0879
Hannah D CoughlanDepartment of Medical Biology, The University of Melbourne, Parkville, VIC, 3010, Australia.
Soroor Hediyeh-ZadehBioinformatics Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3052, Australia.ORCID http://orcid.org/0000-0001-7513-6779
Kira BehrensBlood Cells and Blood Cancer Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3052, Australia.ORCID http://orcid.org/0000-0003-0800-8472
Timothy M JohansonDepartment of Medical Biology, The University of Melbourne, Parkville, VIC, 3010, Australia.
Michael Sze Yuan LowDepartment of Medical Biology, The University of Melbourne, Parkville, VIC, 3010, Australia.
Charles C BellPeter MacCallum Cancer Centre, Parkville, VIC, 3000, Australia.ORCID http://orcid.org/0000-0003-2194-8311
Omer GilanPeter MacCallum Cancer Centre, Parkville, VIC, 3000, Australia.
Yih-Chih ChanPeter MacCallum Cancer Centre, Parkville, VIC, 3000, Australia.ORCID http://orcid.org/0000-0003-2177-5406
Andrew J KuehBlood Cells and Blood Cancer Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3052, Australia.
Thomas BoudierDepartment of Medical Biology, The University of Melbourne, Parkville, VIC, 3010, Australia.ORCID http://orcid.org/0000-0002-0148-7733
Rebecca FelthamInflammation Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3010, Australia.
Anna GabrielyanInflammation Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3010, Australia.
Ladina DiRagoBlood Cells and Blood Cancer Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3052, Australia.
Craig D HylandBlood Cells and Blood Cancer Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3052, Australia.ORCID http://orcid.org/0000-0002-0079-8986
Helen IerinoBlood Cells and Blood Cancer Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3052, Australia.
Sandra MifsudBlood Cells and Blood Cancer Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3052, Australia.
Elizabeth VineyBlood Cells and Blood Cancer Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3052, Australia.
Tracy WillsonBlood Cells and Blood Cancer Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3052, Australia.
Mark A DawsonPeter MacCallum Cancer Centre, Parkville, VIC, 3000, Australia.ORCID http://orcid.org/0000-0002-5464-5029
Rhys S AllanDepartment of Medical Biology, The University of Melbourne, Parkville, VIC, 3010, Australia.ORCID http://orcid.org/0000-0003-0906-2980
Marco J HeroldBlood Cells and Blood Cancer Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3052, Australia.
Kelly RogersDepartment of Medical Biology, The University of Melbourne, Parkville, VIC, 3010, Australia.
David M TarlintonDepartment of Immunology and Pathology, Monash University, Melbourne, VIC, 3004, Australia.ORCID http://orcid.org/0000-0001-9928-686X
Gordon K SmythDepartment of Medical Biology, The University of Melbourne, Parkville, VIC, 3010, Australia.ORCID http://orcid.org/0000-0001-9221-2892
Melissa J DavisDepartment of Medical Biology, The University of Melbourne, Parkville, VIC, 3010, Australia.ORCID http://orcid.org/0000-0003-4864-7033
Stephen L NuttDepartment of Medical Biology, The University of Melbourne, Parkville, VIC, 3010, Australia.ORCID http://orcid.org/0000-0002-0020-6637
Warren S AlexanderBlood Cells and Blood Cancer Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3052, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

B lymphoid development is initiated by the differentiation of hematopoietic stem cells into lineage committed progenitors, ultimately generating mature B cells. This highly regulated process generates clonal immunological diversity via recombination of immunoglobulin V, D and J gene segments. While several transcription factors that control B cell development and V(D)J recombination have been defined, how these processes are initiated and coordinated into a precise regulatory network remains poorly understood. Here, we show that the transcription factor ETS Related Gene (Erg) is essential for early B lymphoid differentiation. Erg initiates a transcriptional network involving the B cell lineage defining genes, Ebf1 and Pax5, which directly promotes expression of key genes involved in V(D)J recombination and formation of the B cell receptor. Complementation of Erg deficiency with a productively rearranged immunoglobulin gene rescued B lineage development, demonstrating that Erg is an essential and stage-specific regulator of the gene regulatory network controlling B lymphopoiesis.

Indexed as

Transcription, GeneticAnimalsB-LymphocytesCell DifferentiationCell LineageCells, CulturedGene Regulatory NetworksHematopoietic Stem CellsLymphopoiesisMice, Inbred C57BLMice, KnockoutOncogene ProteinsPAX5 Transcription FactorTranscriptional Regulator ERGTranscription FactorsV(D)J RecombinationERG protein, mouseOncogene ProteinsPAX5 Transcription FactorTranscriptional Regulator ERGTranscription Factors

Identifiers

PMID32541654
PMCPMC7296042

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.